Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04447495 · ClinicalTrials.gov registry record
Self-sampling for the Study of COVID-19
A clinical trial, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- 126
- Enrollment target
NCT04447495 is a clinical trial that has completed, run by Medical College of Wisconsin. The registered enrollment target is 126 participants.
The verdict
NCT04447495 has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- 126 participants
- Enrollment target
Study Summary
This study will evaluate the feasibility of self-sampling with the iAMP® COVID-19 Detection Kit (Atila BioSystems, Mountain View, CA), a new, low-cost SARS-CoV-2 test that does not require RNA extraction. The investigators will compare the sensitivity and specificity of the iAMP® assay on self-sampled mid-turbinate, anterior nares, and saliva swabs against the gold standard, a nucleic acid amplification testing assay on a clinician-collected nasopharyngeal swab.
Interventions
- DIAGNOSTIC_TEST iAMP test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2020-07-01 |
| Est. Completion | 2020-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04447495
The ClinicalTrials.gov registry entry for NCT04447495 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which iAMP test is the first listed.
NCT04447495 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04447495 about?
NCT04447495 is a clinical study titled "Self-sampling for the Study of COVID-19". This study will evaluate the feasibility of self-sampling with the iAMP® COVID-19 Detection Kit (Atila BioSystems, Mountain View, CA), a new, low-cost SARS-CoV-2 test that does not require RNA extraction. The investigators will compare the sensitivity and specificity of the iAMP® assay on self-sampl...
What is the current status of trial NCT04447495?
This trial is currently completed. The enrollment target is 126 participants. The study started on 2020-07-01. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT04447495?
The interventions under investigation include: iAMP test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04447495?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.